Skip to Content

Amarin Corp PLC ADR AMRN

Morningstar Rating
$0.78 +0.03 (4.68%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AMRN is trading within a range we consider fairly valued.
Price
$0.78
Fair Value
$2.38
Uncertainty
Very High
1-Star Price
$8.76
5-Star Price
$1.80
Economic Moat
Xjfk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AMRN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.75
Day Range
$0.740.80
52-Week Range
$0.631.49
Bid/Ask
$0.77 / $0.79
Market Cap
$320.77 Mil
Volume/Avg
1.2 Mil / 1.4 Mil

Key Statistics

Price/Earnings (Normalized)
60.26
Price/Sales
1.15
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Total Number of Employees
275

Valuation

Metric
AMRN
Price/Earnings (Normalized)
60.26
Price/Book Value
0.59
Price/Sales
1.15
Price/Cash Flow
Price/Earnings
AMRN

Financial Strength

Metric
AMRN
Quick Ratio
1.89
Current Ratio
3.07
Interest Coverage
Quick Ratio
AMRN

Profitability

Metric
AMRN
Return on Assets (Normalized)
0.20%
Return on Equity (Normalized)
0.30%
Return on Invested Capital (Normalized)
−1.55%
Return on Assets
AMRN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
GdthrtnnfZwmnj$853.9 Bil
Johnson & Johnson
JNJ
FkgjmtttdXrtcb$360.7 Bil
Merck & Co Inc
MRK
NjjcfdwMtvy$323.6 Bil
AbbVie Inc
ABBV
PmrnjgnmLjjpg$300.7 Bil
AstraZeneca PLC ADR
AZN
DzqhrsrygCpbpx$245.6 Bil
Roche Holding AG ADR
RHHBY
NpxzwlgvNzbd$229.9 Bil
Novartis AG ADR
NVS
ZgtdjbhfVmpd$227.8 Bil
Amgen Inc
AMGN
WsddgysxBwlx$177.5 Bil
Pfizer Inc
PFE
MzgglzcdKzdjk$163.9 Bil
Sanofi SA ADR
SNY
LfqmsnzfQfyj$128.4 Bil

Sponsor Center